Reply to the letter: "Perampanel may be beneficial in leigh syndrome by its anti-oxidative but not anti-epileptic effect".

Kimura, Shuhei; Shiraishi, Hideaki; Egawa, Kiyoshi; Uchida, Masaya; Ueno, Michihiko

Kimura, Shuhei; Shiraishi, Hideaki; Egawa, Kiyoshi; Uchida, Masaya; Ueno, Michihiko.

Afiliação

Kimura S; Department of Pediatrics, Oji General Hospital, Japan; Department of Pediatrics, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Japan. Electronic address: s.kimura@huhp.hokudai.ac.jp.
Shiraishi H; Department of Pediatrics, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Japan.
Egawa K; Department of Pediatrics, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Japan.
Uchida M; Department of Pediatrics, Sapporo City General Hospital, Japan.
Ueno M; Department of Pediatrics, Teine Keijinkai Hospital, Japan.

Brain Dev ; 43(2): 361-362, 2021 02.

Article em En | MEDLINE | ID: mdl-33317920

Assuntos

Doença de Leigh; Anticonvulsivantes/uso terapêutico; Humanos; Doença de Leigh/tratamento farmacológico; Nitrilas; Piridonas

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Leigh Limite: Humans Idioma: En Revista: Brain Dev Ano de publicação: 2021 Tipo de documento: Article País de publicação: Holanda

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google